The p16INK4A gene encoding a cell cycle regulatory protein, cyclin-dependent kinase 4 inhibitor, is a putative tumor suppressor gene. We examined p16 gene alterations in 11 ovarian cancer cell lines. Three cell lines had homozygous deletion of p16, 1 cell line had multiple intragenic mutations, and there was suppressed transcription of the p16 gene in 1 cell line. Some point mutations were also found in the conserved ankyrin consensus. These observations suggest that abnormalities of p16 are related to ovarian carcinogenesis.
We Ovarian cancer is the most lethal gynecological malignancy. Some genetic alterations have been identified in this tumor, such as inactivation of the p53 tumor suppressor gene1), constitutive activation of the K-ras oncogene2), and amplification of Int-23) and HER-2/neu4). However, the genetic events critical for tumorigenesis have not been well defined. There may be inactivation of additional tumor suppressor genes. Cytogenetic and loss of heterozygosity studies have implicated many regions of the genome in the development of ovarian cancer. For example, 9p is deleted in approximately one third of tumors5 The pair of outer primers were used for complete coding sequence amplification (the PCR product was 502bp). Inner sense and inter antisense primer, inter sense and inner antisense primer were used for SSCP analysis (the PCR products were 226bp and 274bp, respectively). The Control GAPDH primers were designed as follows: (sense): 5'-TGA AGG TCG GAG TCA ACG GAT TTG G-3', (antisense): 5'-CAT GTG GGC CAT GAG GTC CAC CAC-3' (the PCR product was 983bp). p15INK4B primers were designed as follows: (sense): 5'-CAT GAA TTC GGA TCC AGC ATG GCT CCA CCT GCC TTG CCC CGG CCG GCA-3', (antisense): 5'-TGA GAA TTC ATT AGG TGG GAA ATT GGG TAA GAA AAT AAA GTC-3' (the PCR product was 438bp). p21/Wafl primers were designed as follows: The band shift was determined by detecting radioactivity with a BAS1000 (Fuji x, Osaka , Japan) after exposure on an imaging plate for 3 hours . Samples exhibiting band shift on PCR-SSCP analysis were sequenced using template cDNAs amplified with the EB16F and EX16R primer set (the RNA PCR method was described above). The cDNAs (with EcoR1 sites at both the 5' and 3' ends) were purified, digested by EcoR1, and cloned in pUC19. p16INK4A cDNA sequencing was performed using the dideoxy chain termination method and an AmpliCycle sequencing kit (Perkin Elmer), with at least 4 clones in each sample.
Southern blot analysis DNA was extracted from cultured cells using proteinase K and phenol/chloroform treatment, and was precipitated with ethanol. DNA obtained from the 11 ovarian cancer cell lines was digested by the restriction enzyme Kpn1, and the DNA concentration was measured by spectrophotometry, followed by fractionation on 1% agarose gel, and transfer to nylon membranes for Southern blot analysis (Hybond-N+, Amersham International plc, Little Chalfont, Buckinghamshare, England). An antisense (reverse) primer was designed for amplification of p16INK4A exonl (5'-CTG GAT CGG CCT CCG ACC GTA ACT). The probe was prepared from p16INK4A exonl cDNA (144bp) generated by RT-PCR of the PA-1 ovar- Western blot analysis Ovarian cancer cell lines were cultured in RPMI-1640 (10% FBS) in 10-cm tissue culture dishes until subconfluence and were rinsed twice in PBS. Then 5ml of 0.02% EDTA/PBS was added, a rubber policeman was used to scrape off the cells, the cell suspension was transferred to a 15ml-conical tube, and was centrifuged at 1500rpm for and 120mM Tris-HCl pH 6.8) was added. Then the preparation was vortexed for 1min, boiled for 5min, and passed through a 26G needle with a 1ml syringe. After ple buffer (62.5mM Trizma, 2% SDS, 5% glycerol, and 2% 2-mercaptoethanol in distilled water) to 10 units ("OD 280=1" is 1 unit) and 0.4 units of each sample were subjected to SDS-PAGE. Gels were soaked in transfer buffer (48mM Tris-HCl, 39mM glycine, and 20% methanol, pH 9.2) and proteins were transferred to nitrocellulose membranes (CELLOLOSENITRAT, Schleicher & Schuell, Dassel, Germany). Immunoblotting was performed using anti-p16INK4A (Santa Cruz Biotechnology, Santa Cruz, CA), anti-Rb (Pharmingen, San Diego, CA), anticyclin D1 (Seikagaku Co., Chuo, Tokyo, Japan) antibodies. Signals were developed using enhanced chemiluminescense (Amersham International plc).
Results
Southern blot analysis was done on a set of DNAs digested with Kpn1 from the 11 ovarian cancer cell lines. The p16 probe was obtained by RT-PCR amplification of the human p16 exonl cDNA (144bp), which identified fragments of 5.7kb after digestion with KpnI (Fig. 1A) . Southern blots confirmed homozygous deletion of the p16 locus in SKOV, RMG-1, and TYK-nu cells. These findings contrasted with the Southern blots obtained from MCAS, KF, PA-1, KK, Kuramochi (KM), HTOA, HAC-2, and MH cells, which showed an intact band. Thus three of the 11 ovarian cancer cell lines had biallelic loss of the p16 gene.
To further investigate homozygous deletion in these 3
cancer cell lines, we examined p16 mRNA expression using the RT-PCR with specific primers. The cell lines with homozygous p16 deletion had no detectable p16 mRNA (Fig. 1B) , while the remaining cell lines that retained the p16 locus expressed p16 mRNA. However, suppression of p16 gene transcription20) was recognized in KK cells.
The coding region of p16 that spans exons 1-2 was screened for mutations using at least two different sets of SSCP conditions in 6 cell lines that expressed detectable amounts of p16 mRNA. SSCP screening of the exons 1-2 coding sequence of p16 revealed a migration shift of bands in one cell line (MCAS) (data not shown). The cDNA synthesized from MCAS was digested with EcoRI, cloned into the pUC19 vector, and sequenced with Lac Z primers. Three clones were identified in MCAS cDNA: one had an Ala (GCC) to Asp (GAC) substitution at codon 11, Ala (GCG) to Val (GTG) at codon 22, and Val (GTG) to Gly (GGG) at codon 27; another showed Val (GTG) to Gly (GGG) at codon 27 and Ala (GCG) to Thr (ACG) at codon 28 (Fig. 3 right side) : and the third Val (GTG) to Gly (GGG) at codon 27 and Ala (GCC) to Val (GTC) at codon 92 (Fig. 2) . Since MCAS cells did not express the p16 protein, these mutations disturbed the conformation of the protein. Overall, three of the 11 ovarian cancer cell lines showed homozygous deletions (27.3%), one cell line showed base substitutions (9.1%), and one cell line showed transcriptional suppression of the p16 gene. This evidence suggested that p16 was a functional target in varian carcinogenesis. ogenesis of ovarian cancer, we considered whether other gene products directly or indirectly linked to Rb-mediated negative regulation of cell cycle may also have been targeted for mutation, resulting in a phenotype resembling loss of p16 function in the majority of ovarian cancers. Thus, we examined the status of Rb protein by Western blotting in the 11 ovarian cancer cell lines, since loss of Rb protein was positively correlated with p16 protein (Fig. 3) . P16 protein was undetectable in 5 cell lines (SKOV, TYK-nu, KK, RMG-1 and MCAS) due to homozygous deletion or missense mutation of both p16 alleles or else due to transcriptional silencing. These 5 cell lines expressed Rb protein at detectable levels. Rb protein was undetectable in 4 (HAC-2, Kuramochi, MH, and HTOA) of the 6 cell lines that expressed detectable amounts of p16 protein. The tumor cell lines containing Rb protein rarely expressed p16 protein, and conversely p16-expressing tumor cell lines rarely had detectable expression of Rb protein. The KF and PA-1 cell lines expressed both Rb and p16 proteins . However, the existence of cdk4 gene amplification (an alternative mechanism for abrogating Rb-mediated growth regulation) p16 protein was undetectable in 5 cell lines (SKOV, TYK-nu, KK, RMG-1, and MCAS) due to either homozygous deletion or missense mutation on both p16 alleles, or due to transcriptional silencing of p16 gene. These 5 cell lines all expressed Rb protein at detectable levels. In contrast, Rb protein was undetectable in 4 (HAC-2, Kuramochi, MH, and HTOA) of the 6 cell lines that expressed detectable amounts of p16 protein. KF and PA-1 cells expressed both Rb and p16 proteins. Detectable levels of cyclin D protein were recognized in all 11 cell lines. To investigate the counter-regulatory factor that diminishes cdk4 activity, we examined these 11 ovarian cancer cell lines for p15, p21, and p27 mRNA expression using the RT-PCR (data not shown). Both p21 and p27 mRNAs were detectable in all 11 cell lines (Table 1) . GAPDH cDNA was amplified simultaneously for relative quantification. Two of the 3 cell lines (SKOV and TYKnu) with homozygous deletion of the p16 locus did not express p15 mRNA and one (RMG-1) expressed p15 mRNA. Southern blot analysis confirmed the maintenance of an intact p15 gene in all cell lines (Fig. 1A) . Thus, homozygous deletion of the p15 gene appeared to be far less common than that of the p16 gene in ovarian cancers. These observations suggested that perturbation of Rb- 
